Donate

With Patient Perspectives in Mind, ICER Evaluates Hemophilia Therapies

October 30, 2020

On October 30th, 2020, the Institute for Clinical and Economic Review (ICER) held a public meeting to discuss its evidence report on therapies for hemophilia A. ICER is an independent and non-partisan research organization that evaluates the clinical and economic value of prescription drugs, medical tests, and other healthcare and healthcare delivery innovations. For this […]

Washington Wire: September 2019

September 30, 2019

The drug pricing debate聽in Washington resumed when Congress returned from its summer recess 鈥 though many observers question whether Congress will be able to pass legislation this year, due to policy disagreements between the majority and minority parties; the short period of time available before the 2020 elections; and the spillover effects of the impeachment […]


Sign up for E-mails, Dateline Magazine, and other ways to stay connected.